Cause of death, by non-communicable diseases in Europe & Central Asia (IDA & IBRD countries)
Europe & Central Asia (IDA & IBRD countries): Cause of death, by non-communicable diseases was 67.7% in 2021. ▼ Falling
Cause of death, by non-communicable diseases in Europe & Central Asia (IDA & IBRD countries), 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total.
Analysis
The most recent figure for cause of death, by non-communicable diseases in Europe & Central Asia (IDA & IBRD countries) is 67.7%, measured in 2021. That is the lowest value across all 6 years on record.
That represents a change of down 10.3% on the previous year and down 22.8% over ten years.
Over the whole period, cause of death, by non-communicable diseases in Europe & Central Asia (IDA & IBRD countries) peaked at 89.7% in 2019 and was at its lowest, 67.7%, in 2021.
Europe & Central Asia (IDA & IBRD countries) ranks 16th of 47 groups on this measure, in the middle of the range.
Cause of death, by non-communicable diseases in Europe & Central Asia (IDA & IBRD countries), year by year
| Year | % of total | Change |
|---|---|---|
| 2000 | 84.3% | — |
| 2010 | 87.7% | +4.0% |
| 2015 | 88.5% | +1.0% |
| 2019 | 89.7% | +1.3% |
| 2020 | 75.5% | -15.8% |
| 2021 | 67.7% | -10.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.3% | 84.3% | 84.3% | 1 |
| 2010s | 88.6% | 87.7% | 89.7% | 3 |
| 2020s | 71.6% | 67.7% | 75.5% | 2 |
Countries ranked near Europe & Central Asia (IDA & IBRD countries)
More health data for Europe & Central Asia (IDA & IBRD countries)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.34 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0402 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -0.0639 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -0.1882 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.035 units per person (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases in Europe & Central Asia (IDA & IBRD countries)?
- Cause of death, by non-communicable diseases in Europe & Central Asia (IDA & IBRD countries) was 67.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases recorded in Europe & Central Asia (IDA & IBRD countries)?
- The highest recorded value was 89.7% in 2019.
- What is the lowest cause of death, by non-communicable diseases recorded in Europe & Central Asia (IDA & IBRD countries)?
- The lowest recorded value was 67.7% in 2021.
- How does Europe & Central Asia (IDA & IBRD countries) rank for cause of death, by non-communicable diseases?
- Europe & Central Asia (IDA & IBRD countries) ranks 16th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases rising or falling in Europe & Central Asia (IDA & IBRD countries)?
- Over the last ten years it is down 22.8%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia (IDA & IBRD countries) data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases (% of total). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Cause of death refers to the share of all deaths for all ages by underlying causes. Non-communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.